Trial intelligence / Profile preview

Timolol for Prevention of Varices in Cirrhosis

NCT00006398Phase 3Completed

Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases
Start
Aug 1993
Primary completion
Sep 2002
Modality
Small Molecules
Countries
3
01

Overview

Phase 3, randomised, double-blind trial in esophageal and gastric varices comparing Timolol Maleate with Placebo (2 arms). Primary endpoint: Appearance of gastroesophageal varices at 6 years. Started Aug 1993; status: completed.

02

Drugs

timolol
03

Conditions

esophageal and gastric varices

Beyond the preview

Go deeper on NCT00006398.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00006398.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call